Fluencia aims to address challenges in women’s reproductive health by enabling continuous monitoring of key reproductive hormones (such as estradiol) via a wearable biosensor. The system is based on microneedle-like sampling of interstitial fluid (ISF), which provides a minimally invasive yet physiologically relevant fluid reservoir. On this substrate, Fluencia integrates nanomaterial-based transducers (e.g., FET devices), leveraging prior work in our chair on highly sensitive bioelectronic sensors.
By continuously tracking hormonal fluctuations, Fluencia could significantly improve therapeutic decision-making during assisted reproduction (e.g., IVF), helping to time interventions more precisely and mitigate risks such as ovarian hyperstimulation.
During the seminar, we will:
Practice and refine the pitch narrative, clearly articulating Fluencia’s value proposition (scientific innovation, medical need, and path to market).
Simulate the pitch delivery under realistic conditions and collect structured feedback on clarity, flow, and impact.
Review how to best communicate the technical novelty — such as our nanomaterial FET-based detection — and its commercialization potential in reproductive medicine.
Address possible concerns and questions that might come up during the EXIST Forschungstransfer pitch, including scalability, biocompatibility, and patient adoption.
Alexandra Parichenko studied Nanobiophysics at Technical University of Dresden (TUD) and received her Master’s degree in 2021. Her Master’s thesis was mainly conducted at Fraunhofer IKTS under supervision of Dr. Natalia Beshchasna and Dr. Jörg Opitz. In the frame of the thesis she investigated diamond nanoparticles and high density lipoprotein nanoparticles as potential anti-atherogenic agents, which can be integrated into the biodegradable coating of vascular stents. In 2020 she joined Prof. Gianaurelio Cuniberti’s chair and now is focusing on investigation of different hydrogels for hosting bio-receptors on the surfaces of biosensors, such as nanowire field effect transistors (FETs) and carbon nanotubes FETs.
Fluencia aims to address challenges in women’s reproductive health by enabling continuous monitoring of key reproductive hormones (such as estradiol) via a wearable biosensor. The system is based on microneedle-like sampling of interstitial fluid (ISF), which provides a minimally invasive yet physiologically relevant fluid reservoir. On this substrate, Fluencia integrates nanomaterial-based transducers (e.g., FET devices), leveraging prior work in our chair on highly sensitive bioelectronic sensors.
By continuously tracking hormonal fluctuations, Fluencia could significantly improve therapeutic decision-making during assisted reproduction (e.g., IVF), helping to time interventions more precisely and mitigate risks such as ovarian hyperstimulation.
During the seminar, we will:
Practice and refine the pitch narrative, clearly articulating Fluencia’s value proposition (scientific innovation, medical need, and path to market).
Simulate the pitch delivery under realistic conditions and collect structured feedback on clarity, flow, and impact.
Review how to best communicate the technical novelty — such as our nanomaterial FET-based detection — and its commercialization potential in reproductive medicine.
Address possible concerns and questions that might come up during the EXIST Forschungstransfer pitch, including scalability, biocompatibility, and patient adoption.
Alexandra Parichenko studied Nanobiophysics at Technical University of Dresden (TUD) and received her Master’s degree in 2021. Her Master’s thesis was mainly conducted at Fraunhofer IKTS under supervision of Dr. Natalia Beshchasna and Dr. Jörg Opitz. In the frame of the thesis she investigated diamond nanoparticles and high density lipoprotein nanoparticles as potential anti-atherogenic agents, which can be integrated into the biodegradable coating of vascular stents. In 2020 she joined Prof. Gianaurelio Cuniberti’s chair and now is focusing on investigation of different hydrogels for hosting bio-receptors on the surfaces of biosensors, such as nanowire field effect transistors (FETs) and carbon nanotubes FETs.
